Average Co-Inventor Count = 3.18
ph-index = 5
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Neurelis, Inc. (5 from 6 patents)
2. Questcor Pharmaceuticals, Inc. (3 from 6 patents)
3. Hale Biopharma Ventures, LLC (3 from 3 patents)
4. Rhode Island Hospital (2 from 110 patents)
5. Mallinckrodt Ard IP Limited (2 from 2 patents)
6. Aegis Therapeutics, LLC (1 from 35 patents)
13 patents:
1. 12337061 - Administration of benzodiazepine compositions
2. 12324852 - Administration of benzodiazepine compositions
3. 12268664 - Administration of benzodiazepine compositions
4. 11793786 - Administration of benzodiazepine compositions
5. 11241414 - Administration of benzodiazepine compositions
6. 10286041 - ACTH prophylactic treatment of renal disorders
7. 10232018 - ACTH for treatment of acute respiratory distress syndrome
8. 9763876 - Administration of benzodiazepine compositions
9. 9550822 - ACTH prophylactic treatment of renal disorders
10. 8895546 - Administration of benzodiazepine compositions
11. 8796416 - ACTH prophylactic treatment of renal disorders
12. 8530463 - Multimodal particulate formulations
13. 7608616 - Methods for reducing the risk of an adverse drug interaction in a patient suffering from insomnia